Atıf İçin Kopyala
Yilmaz S., ÜNAL F., Yuzbasioglu D., Gonenc İ. M.
HUMAN & EXPERIMENTAL TOXICOLOGY, cilt.34, sa.3, ss.284-288, 2015 (SCI-Expanded)
-
Yayın Türü:
Makale / Tam Makale
-
Cilt numarası:
34
Sayı:
3
-
Basım Tarihi:
2015
-
Doi Numarası:
10.1177/0960327114537846
-
Dergi Adı:
HUMAN & EXPERIMENTAL TOXICOLOGY
-
Derginin Tarandığı İndeksler:
Science Citation Index Expanded (SCI-EXPANDED), Scopus
-
Sayfa Sayıları:
ss.284-288
-
Anahtar Kelimeler:
Clomiphene citrate, genotoxicity, sister chromatid exchanges, cell cycle delay, CANCER INCIDENCE, OVARIAN-CANCER, OVULATION INDUCTION, FERTILITY DRUGS, UTERINE-CANCER, BREAST-CANCER, IN-VIVO, RISK, INFERTILITY, COHORT
-
Ankara Üniversitesi Adresli:
Evet
Özet
Objective: Clomiphene citrate (CC) is a selective estrogen receptor modulator and is used for the treatment of in vitro fertilization, intracytoplasmic sperm injection, intrauterine insemination, and so on. In this study, sister chromatid exchanges (SCEs) and cell cycle delays were analyzed to investigate genotoxicity and cytotoxicity of CC in peripheral blood lymphocytes of healthy women.